Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baloxavir Resistance Markers in Influenza A and B Viruses in the Americas.
Acocal-Juárez E, Márquez-Domínguez L, Vallejo-Ruíz V, Cedillo L, Santos-López G. Acocal-Juárez E, et al. Among authors: vallejo ruiz v. Drug Healthc Patient Saf. 2024 Sep 14;16:105-113. doi: 10.2147/DHPS.S470868. eCollection 2024. Drug Healthc Patient Saf. 2024. PMID: 39296541 Free PMC article.
Molecular aspects of cervical cancer: a pathogenesis update.
Vallejo-Ruiz V, Gutiérrez-Xicotencatl L, Medina-Contreras O, Lizano M. Vallejo-Ruiz V, et al. Front Oncol. 2024 Mar 19;14:1356581. doi: 10.3389/fonc.2024.1356581. eCollection 2024. Front Oncol. 2024. PMID: 38567159 Free PMC article. Review.
Antiviral resistance in influenza viruses.
Márquez Domínguez L, Márquez Matla K, Reyes Leyva J, Vallejo Ruíz V, Santos López G. Márquez Domínguez L, et al. Among authors: vallejo ruiz v. Cell Mol Biol (Noisy-le-grand). 2023 Dec 10;69(13):16-23. doi: 10.14715/cmb/2023.69.13.3. Cell Mol Biol (Noisy-le-grand). 2023. PMID: 38158694 Review.
Galectin-9 Expression is Correlated to Cervical Squamous Cell Carcinoma Progression and Overall Survival.
Mendieta-Carmona V, Delgado-López G, Reyes-Leyva J, Gutiérrez-Quiroz CT, Vazquez-Zamora VJ, Picazo-Mendoza DA, Montiel-Jarquín AJ, Martinez-Morales LP, Vallejo-Ruiz V. Mendieta-Carmona V, et al. Among authors: vallejo ruiz v. Onco Targets Ther. 2023 Oct 31;16:891-904. doi: 10.2147/OTT.S433710. eCollection 2023. Onco Targets Ther. 2023. PMID: 37927328 Free PMC article.
Editorial: Therapeutic targeting of splicing variants in cancer.
Sarvari P, Rubio K, Dobersch S, Ntokou A, Vallejo-Ruiz V. Sarvari P, et al. Among authors: vallejo ruiz v. Front Pharmacol. 2023 May 5;14:1206342. doi: 10.3389/fphar.2023.1206342. eCollection 2023. Front Pharmacol. 2023. PMID: 37214461 Free PMC article. No abstract available.
Response to Article "Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages" [Response to Letter].
Reyes-Vallejo T, Conde-Rodríguez I, Serna-Villalobos J, Ramírez-Díaz I, Pérez-Villalobos G, Delgado-López G, Vázquez-Zamora VJ, Gutierrez-Quiroz CT, Ávila-Jiménez L, García-Carrancá A, Martínez-Acosta L, Santos-López G, Reyes-Leyva J, Vallejo-Ruiz V. Reyes-Vallejo T, et al. Among authors: vallejo ruiz v. Onco Targets Ther. 2022 Dec 22;15:1543-1544. doi: 10.2147/OTT.S399119. eCollection 2022. Onco Targets Ther. 2022. PMID: 36579183 Free PMC article. No abstract available.
78 results